United States · FDA National Drug Code directory
Alvimopan
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0054-0668_89b02f3c-d8da-4b1f-9847-859c4efffabb
- Product NDC
- 0054-0668
- Form
- CAPSULE
- Composition / generic term
- Alvimopan
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20240206
- Source listing expiry
- 20261231
Source-listed ingredients
- ALVIMOPAN — 12 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (0054-0668-82) / 5 CAPSULE in 1 BLISTER PACK · 0054-0668-82
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →